Nutra Pharma insider gifts 12M preferred shares
Nutra Pharma Corp (NPHC) insider and ten percent owner Rik J. Deitsch reported a bona fide gift of 12,000,000 shares of Series B Preferred Stock on 2026-08-21, leaving him with 0 Series B Preferred shares reported after the transaction.
Rhea-AI Filing Summary
Nutra Pharma Corp (NPHC) insider and ten percent owner Rik J. Deitsch reported a bona fide gift of 12,000,000 shares of Series B Preferred Stock on 2026-08-21, leaving him with 0 Series B Preferred shares reported after the transaction. He continues to hold 43,298,859 shares of Common Stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
12,000,000 shares gifted
Gift
2 txns
Insider
DEITSCH RIK J
Role
10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Series B Preferred Stock | 12,000,000 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Series B Preferred Stock — 0 shares (Direct);
Common Stock — 43,298,859 shares (Direct)
Key Figures
Series B Preferred Stock gifted: 12,000,000 shares
Series B Preferred Stock held after transaction: 0 shares
Common Stock held: 43,298,859 shares
+2 more
5 metrics
Series B Preferred Stock gifted
12,000,000 shares
Bona fide gift on 2026-08-21
Series B Preferred Stock held after transaction
0 shares
Total Series B Preferred shares following gift
Common Stock held
43,298,859 shares
Direct Common Stock holdings as of 2026-08-21
Gift transactions
1 transaction
Gift disposition count in transaction summary
Gifted shares total
12,000,000 shares
Gift shares in transaction summary
Key Terms
Bona fide gift, ten percent owner, Series B Preferred Stock, Form 4
4 terms
Bona fide gift regulatory
"transaction_code_description: "Bona fide gift" for the Series B Preferred"
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
ten percent owner regulatory
"reporting person is marked as a ten percent owner"
Series B Preferred Stock financial
"security_title: "Series B Preferred Stock" in the transaction record"
Series B preferred stock is a type of ownership share issued by a company that offers certain advantages over common stock, such as priority in receiving dividends or assets if the company is sold or liquidated. It is typically issued after an initial round of funding, making it a way for investors to support a company's growth while gaining some protections and benefits. This stock matters to investors because it often provides a more secure investment position with potential for future growth.
Form 4 regulatory
"INSIDER FILING DATA (Form 4) for transactions in NPHC"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What insider transaction did NPHC report for Rik J. Deitsch on this Form 4?
Rik J. Deitsch reported a bona fide gift of 12,000,000 shares of Nutra Pharma Corp Series B Preferred Stock on 2026-08-21, with no price reported for the transfer.
Was the NPHC insider transaction a buy or a sell?
The NPHC insider transaction was reported as a disposition via bona fide gift (code G), not a market purchase or sale, for 12,000,000 Series B Preferred shares.
Did the NPHC Form 4 indicate use of a Rule 10b5-1 trading plan?
No. The Form 4 data indicates the Rule 10b5-1 checkbox is false, meaning the filer did not affirm that the reported transactions were made under a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
